You just read:

KOMBOGLYZE™ (saxagliptin and metformin HCl Immediate-Release) Receives Positive CHMP Opinion in the European Union for the Treatment of Type 2 Diabetes

News provided by

Bristol-Myers Squibb Company and AstraZeneca

23 Sep, 2011, 15:34 BST